Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
- PMID: 23064436
- PMCID: PMC3565564
- DOI: 10.1016/j.nbd.2012.10.011
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
Abstract
The pathogenic mechanisms that underlie Parkinson's disease remain unknown. Here, we review evidence from both sporadic and genetic forms of Parkinson's disease that implicate both mitochondria and oxidative stress as central players in disease pathogenesis. A systemic deficiency in complex I of the mitochondrial electron transport chain is evident in many patients with the disease. Oxidative stress caused by reactive metabolites of dopamine and alterations in the levels of iron and glutathione in the substantia nigra accompany this mitochondrial dysfunction. Recent evidence from studies on the genetic forms of parkinsonism with particular stress on DJ-1, parkin, and PINK-1 also suggest the involvement of mitochondria and oxidative stress.
Copyright © 2012 Elsevier Inc. All rights reserved.
References
-
- Alam ZI, et al. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. Journal of neurochemistry. 1997;69:1196–203. - PubMed
-
- Anvret A, et al. Variations of the CAG trinucleotide repeat in DNA polymerase gamma (POLG1) is associated with Parkinson’s disease in Sweden. Neuroscience letters. 2010;485:117–20. - PubMed
-
- Bandmann O, et al. Mitochondrial DNA polymorphisms in pathologically proven Parkinson’s disease. Journal of neurology. 1997;244:262–5. - PubMed
-
- Bandopadhyay R, et al. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson’s disease. Brain. 2004;127:420–30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
